Notes to the consolidated financial statements for the year ended 31 December 2007 34.
Events after the balance sheet date Since the year-end, the Group has acquired four companies: Oncology Inc. in the US, White Sheep in Finland, CIMA Group in Latin America and PS&A in the UK.
The total maximum consideration in respect of these acquisitions is 12.5 million.
The assessment of the purchases price allocation in respect of these acquisitions is currently being performed.
Related party transactions Remuneration of key management personnel The following is the compensation of directors and key management.
Further information about the remuneration of individual directors is provided in the audited part of the Directors Remuneration Report on pages 59 to 63.
2007 2006 m m Short-term employee benefits 5.9 5.3 Post-employment benefits 0.7 0.6 Other long-term benefits Termination benefits - Share-based payment 2.7 1.7 9.3 7.6 Transactions with associated undertakings In 2007, Group companies purchased media space from associated undertakings totalling 37.6 million 2006: 23.3 million.
The balance due from Group companies to associated undertakings at the end of 2007 was 8.1 million 2006: 0.1 million.
The balance due from associated undertakings to Group companies at the end of 2007 was 0.8 million 2006: 0.7 million.
